Tools
Tools
Mechan, Frank, Praulins, Giorgio, Gillespie, Jack, Gleave, Katherine, Murphy, Annabel, McDermott, Daniel, Weetman, David 
ORCID: https://orcid.org/0000-0002-5820-1388 and Lees, Rosemary ORCID: https://orcid.org/0000-0002-4232-9125
(2024)
'Power calculation for mosquito bioassays: Quantifying variability in the WHO tube bioassay and developing sample size guidance for the PBO synergism assay using a Shiny application'. Gates Open Research, Vol 8, p. 96.
|
Text
b73a149e-bc35-4f8b-b44c-771482829834_16123_-_frank_mechan.pdf - Published Version Available under License Creative Commons Attribution. Download (1MB) | Preview |
Abstract
Background
The WHO tube bioassay is a method for exposing mosquitos to determine susceptibility to insecticides, with mortality to discriminating doses <98% indicating possible resistance and <90% confirming resistance. This bioassay is also used for synergism testing to assess if susceptibility is restored by pre-exposure to the synergist piperonyl butoxide.
Methods
Here we perform testing with pyrethroid-susceptible and pyrethroid-resistant An. gambiae to quantify the variability of the WHO tube bioassay and identify its sources. These estimates of within and between day variability are then used to evaluate the power of the bioassay to detect a mortality difference between pyrethroid-only and pyrethroid-PBO.
Results
We show that approximately two-thirds of variation occurs between days, with the pyrethroid-susceptible strain twice as variable as the pyrethroid-resistant strain. The total number of mosquitoes in the tube and their bodyweight contributes to approximately 10% of this variability. Changes in temperature and humidity, within a climate-controlled insectary, didn’t impact mortality. Using a simulation-based framework, we show that the current synergism guidelines, using a 4x4 design, can reliably detect a difference between 90% and 100% mortality (>90% power). However, as the mortality of either group gets closer to 50%, a 10% difference between groups is more difficult to reliably detect. In the worst-case scenario where the mortality of either group is 50%, the mortality difference must be >22.5% to be detected with 80% power. We provide an R shiny application to assess power for other comparisons.
Conclusions
Our findings indicate that detecting synergism with the WHO tube assay is more difficult than assumed by the current WHO guidelines. Additionally, we demonstrate the value of using a Shiny application to make the outputs of simulation-based power analysis readily available to end-users, allowing them to determine the number of tubes needed to detect a given mortality difference.
| Item Type: | Article |
|---|---|
| Subjects: | QX Parasitology > Insects. Other Parasites > QX 510 Mosquitoes WB Practice of Medicine > WB 26 Equipment and supplies |
| Faculty: Department: | Biological Sciences > Vector Biology Department IVCC |
| Digital Object Identifer (DOI): | https://doi.org/10.12688/gatesopenres.16123.1 |
| SWORD Depositor: | JISC Pubrouter |
| Depositing User: | JISC Pubrouter |
| Date Deposited: | 07 Oct 2024 15:21 |
| Last Modified: | 07 Oct 2024 15:21 |
| URI: | https://archive.lstmed.ac.uk/id/eprint/25381 |
Statistics
Actions (login required)
 |
Edit Item |